Jonathan Slonin - Aug 3, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Clinical Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Aug 3, 2022
Transactions value $
-$17,156
Form type
4
Date filed
8/5/2022, 04:04 PM
Previous filing
Jul 7, 2022
Next filing
Jun 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$17.2K -308 -0.82% $55.70 37.1K Aug 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.